Your browser doesn't support javascript.
loading
Surging Liver Transplantation for Nonalcoholic Steatohepatitis from 2000-2022: A National Database Study.
Ajayi, Tokunbo; Moon, Gina; Chen, Sixia; Pan, Steven; Oseini, Abdul; Houchen, Courtney.
Afiliação
  • Ajayi T; From the Section of Digestive Diseases and Nutrition.
  • Moon G; Department of Medicine.
  • Chen S; Section of Biostatistics and Epidemiology, Hudson College of Public Health.
  • Pan S; Section of Biostatistics and Epidemiology, Hudson College of Public Health.
  • Oseini A; Department of Transplant Surgery, Section of Transplant, University of Oklahoma Health Sciences Center, Oklahoma City.
  • Houchen C; From the Section of Digestive Diseases and Nutrition.
South Med J ; 117(6): 302-310, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38830583
ABSTRACT

OBJECTIVES:

Our aim was to provide an up-to-date, large-scale overview of the trends and clinicodemographics for NASH LTs performed in the United States compared with all other LT indications between 2000 and 2022. We also examined the demographic factors that will predict future demand for NASH LT.

METHODS:

Our analysis of NASH LT from the Organ Procurement & Transplantation Network database spanning 2000-2022 consisted primarily of descriptive statistics and hypothesis testing with corrections for multiple testing when necessary. Trend lines and linear correlations were also explored.

RESULTS:

NASH LTs have experienced a remarkable surge, escalating from 0.12% of all LTs in 2000 to a substantial 14.7% in 2022, marking a 100-fold increase. Examining demographic trends, a significant proportion of NASH LTs recipients fall within the 50- to 64-year-old age group. Moreover, 52% of these recipients concurrently exhibit type 2 diabetes mellitus, a notably higher percentage than the 19% observed in all LT recipients. Type 2 diabetes mellitus emerges as a prominent risk factor for NASH progressing to end-stage liver disease. The phenomenon of repeat transplantation is noteworthy; although 6% of all LTs necessitate repeat procedures, this figure dramatically drops to 0.6% for NASH LTs. Ethnic disparities are apparent, with African Americans representing a mere 2% of NASH LT recipients, significantly lower than their representation in the overall population. Regionally, the East Coast has a higher proportion of NASH LT recipients compared with waitlist additions. This trend holds true across demographics.

CONCLUSIONS:

Our findings underscore the need for increased resources, particularly for minority, uninsured, or noncitizen individuals requiring LT for NASH. This analysis provides valuable insights into the dynamic landscape of LTs in the context of NASH, shaping the trajectory of medical interventions in the 21st century.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bases de Dados Factuais / Transplante de Fígado / Hepatopatia Gordurosa não Alcoólica Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: South Med J Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bases de Dados Factuais / Transplante de Fígado / Hepatopatia Gordurosa não Alcoólica Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: South Med J Ano de publicação: 2024 Tipo de documento: Article
...